Cite
MLA Citation
L.C. Harshman et al.. “807PFirst interim results of the radium-223 (Ra-223) REASSURE observational study: Analysis of patient (Pt) characteristics and safety by use of abiraterone and/or enzalutamide (Abi/Enza).” Annals of oncology, vol. 28, n.d., p. . http://access.bl.uk/ark:/81055/vdc_100097077855.0x00001c